New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
10:03 EDTLO, AHT, SAP, RNF, WTS, STAA, PTEN, CVLT, ALDW, KOG, POT, TCP, REGN, MMLP, BHI, AGU, PSA, SI, POSTOn The Fly: Analyst Upgrade Summary
Alon USA Partners (ALDW) upgraded to Buy from Neutral at Citigroup... Ashford Hospitality (AHT) upgraded to Outperform from Market Perform at JMP Securities... Baker Hughes (BHI) upgraded to Buy from Neutral at Goldman... CommVault (CVLT) upgraded to Buy from Neutral at Mizuho... Lorillard (LO) upgraded to Buy from Neutral at Goldman... Martin Midstream Partners (MMLP) upgraded to Buy from Neutral at UBS... Patterson-UTI Energy (PTEN) upgraded to Conviction Buy from Neutral at Goldman... Post Holdings (POST) upgraded to Buy from Neutral at SunTrust... Regeneron (REGN) upgraded to Buy from Neutral at Citigroup... STAAR Surgical (STAA) upgraded to Buy from Hold at Canaccord... Siemens (SI) upgraded to Buy from Neutral at BofA/Merrill... TC PipeLines (TCP) upgraded to Buy from Neutral at UBS... Watts Water (WTS) upgraded to Buy from Hold at BB&T... Public Storage (PSA) upgraded to Outperform from Neutral at Macquarie... Potash (POT) upgraded to Market Perform from Underperform at Cowen... Rentech Nitrogen (RNF) upgraded to Market Perform from Underperform at Cowen... Agrium (AGU) upgraded to Market Perform from Underperform at Cowen... Kodiak Oil & Gas (KOG) upgraded to Buy from Accumulate at KLR Group... SAP (SAP) upgraded to Buy from Neutral at Citigroup.
News For ALDW;AHT;BHI;CVLT;LO;MMLP;PTEN;POST;REGN;STAA;SI;TCP;WTS;PSA;POT;RNF;AGU;KOG;SAP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 20, 2015
10:07 EDTPTENHigh option volume stocks
Subscribe for More Information
10:00 EDTREGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:32 EDTMMLPMartin Midstream Partners to host analyst and investor day
Analyst and Investor day will be held in Houston on March 24 at 10 am. Webcast Link
09:22 EDTBHIHalliburton, Baker Hughes to seek buyers for $10B in assets, Bloomberg says
Subscribe for More Information
08:05 EDTREGNRegeneron initiated with a Buy at Chardan
Subscribe for More Information
07:19 EDTBHIWhite House expected to unveil fracking rules today, WSJ says
Subscribe for More Information
March 19, 2015
11:07 EDTSAPSAP board recommends dividend increase of 10%
Subscribe for More Information
March 18, 2015
17:30 EDTPOTPotash sees FY15 pre-tax earnings reduced C$75M-C$100M due to tax changes
Subscribe for More Information
11:14 EDTPOSTPost reaffirms MOM Brands acquisition immediately accretive
Subscribe for More Information
10:21 EDTSAPHigh option volume stocks:
Subscribe for More Information
07:21 EDTKOGE&P stocks should be bought on weakness, says Stifel
Subscribe for More Information
March 17, 2015
13:42 EDTPOTPotash upgraded to Buy from Hold at Societe Generale
Subscribe for More Information
07:17 EDTRNFRentech Nitrogen sees Q1 ammonia delivires 32,000 tons
Subscribe for More Information
07:14 EDTRNFRentech Nitrogen sees FY15 340,000 tons ammonia production at East Dubuque
Subscribe for More Information
07:12 EDTSAPDeutsche Messe to hold a conference
CeBIT 2015 is being held in Hannover, Germany on March 15-20.
07:06 EDTRNFRentech Nitrogen reports Q4 EPS with items 20c, consensus 13c
Reports Q4 revenue $80.56M, consensus $64.77M. Reports EPS 6c excluding loss allocated to unvested units and the Agrifos settlement.
March 16, 2015
09:46 EDTSAPAccenture and SAP selected by CenterPoint Energy to develop analytics solution
Subscribe for More Information
08:23 EDTREGNPCSK9 data continues to impress, says Leerink
Subscribe for More Information
07:16 EDTREGNRegeneron Sanofi dupilumab drug can generate $6B+ in revenue, says Bernstein
Bernstein believes that dupilumab, a drug made by Regeneron and Sanofi, has shown strong efficacy in patients with severe atopic dermatitis. The firm notes that the drug is currently in pivotal trials involving patients with severe levels of other common diseases. The firm thinks the drug can generate $1.5B of revenue by 2018 and $3.8B by 2020. Bernstein keeps a $500 price target and Outperform rating on Regeneron.
06:40 EDTREGNPCSK9 studies show potential improvement in heart health, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use